» Articles » PMID: 35602854

BEHAVIORAL HAZARD IN HEALTH INSURANCE

Overview
Journal Q J Econ
Date 2022 May 23
PMID 35602854
Authors
Affiliations
Soon will be listed here.
Abstract

A fundamental implication of standard moral hazard models is overuse of low-value medical care because copays are lower than costs. In these models, the demand curve alone can be used to make welfare statements, a fact relied on by much empirical work. There is ample evidence, though, that people misuse care for a different reason: mistakes, or "behavioral hazard." Much high-value care is underused even when patient costs are low, and some useless care is bought even when patients face the full cost. In the presence of behavioral hazard, welfare calculations using only the demand curve can be off by orders of magnitude or even be the wrong sign. We derive optimal copay formulas that incorporate both moral and behavioral hazard, providing a theoretical foundation for value-based insurance design and a way to interpret behavioral "nudges." Once behavioral hazard is taken into account, health insurance can do more than just provide financial protection - it can also improve health care efficiency.

Citing Articles

What Can Economics Say about Alzheimer's Disease?.

Chandra A, Coile C, Mommaerts C J Econ Lit. 2025; 61(2):428-470.

PMID: 39917255 PMC: 11801801. DOI: 10.1257/jel.20211660.


Pharmacy Subscription Program and Medication Refills, Days' Supply, and Out-of-Pocket Costs.

Yeung K, Wilden D, Gupta V, Matlin O JAMA Netw Open. 2025; 8(1):e2456392.

PMID: 39869337 PMC: 11774089. DOI: 10.1001/jamanetworkopen.2024.56392.


Economic Evidence on Cost Sharing and Alternative Insurance Designs to Address Moral and Behavioral Hazards in High-Income Health Care Systems: A Systematic Review.

Graf M, Baumgardner J, Neumann U, Brewer I, Chou J, Fendrick A J Mark Access Health Policy. 2024; 12(4):342-368.

PMID: 39588278 PMC: 11587077. DOI: 10.3390/jmahp12040027.


The Health Costs of Cost Sharing.

Chandra A, Flack E, Obermeyer Z Q J Econ. 2024; 139(4):2037-2082.

PMID: 39391632 PMC: 11461808. DOI: 10.1093/qje/qjae015.


THE EFFECT OF INSURANCE COVERAGE ON PREVENTIVE CARE.

Cabral M, Cullen M Econ Inq. 2024; 55(3):1452-1467.

PMID: 39144615 PMC: 11323042. DOI: 10.1111/ecin.12442.


References
1.
Gao X, Nau D, ROSENBLUTH S, Scott V, Woodward C . The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000; 12(4):387-98. DOI: 10.1080/09540120050123783. View

2.
Goldman D, Joyce G, Escarce J, Pace J, Solomon M, Laouri M . Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004; 291(19):2344-50. DOI: 10.1001/jama.291.19.2344. View

3.
Manning W, NEWHOUSE J, Duan N, Keeler E, Leibowitz A, Marquis M . Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev. 1987; 77(3):251-77. View

4.
Jarvik J, Hollingworth W, Martin B, Emerson S, Gray D, Overman S . Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trial. JAMA. 2003; 289(21):2810-8. DOI: 10.1001/jama.289.21.2810. View

5.
Lakdawalla D, Sood N . Innovation and The Welfare Effects of Public Drug Insurance. J Public Econ. 2010; 93(3-4):541-548. PMC: 2865693. DOI: 10.1016/j.jpubeco.2008.11.003. View